| Year |
Citation |
Score |
| 2018 |
Sherman KE, Rouster SD, Kang M, Umbleja T, Sterling R, Butt AA. PNPLA3 Gene Polymorphisms in HCV/HIV-Coinfected Individuals. Digestive Diseases and Sciences. PMID 30218427 DOI: 10.1007/S10620-018-5278-Y |
0.339 |
|
| 2018 |
Cespedes MS, Kang M, Kojic EM, Umbleja T, Godfrey C, Webster-Cyriaque JY, Masih R, Firnhaber C, Grinsztejn B, Saah A, Cu-Uvin S, Aberg JA. Anogenital Human Papillomavirus Virus DNA and Sustained Response to the Quadrivalent HPV Vaccine in Women Living with HIV-1. Papillomavirus Research (Amsterdam, Netherlands). PMID 30118852 DOI: 10.1016/J.Pvr.2018.08.002 |
0.38 |
|
| 2018 |
Wyles DL, Kang M, Matining RM, Murphy RL, Peters MG. Similar Low Rates of HCV Recurrence in HCV/HIV- and HCV-Infected Participants who Achieved SVR After DAA Treatment: Interim Results From the ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS). Open Forum Infectious Diseases. 5: ofy103. PMID 29977962 DOI: 10.1093/Ofid/Ofy103 |
0.39 |
|
| 2018 |
Hosseinipour MC, Kang M, Krown SE, Bukuru A, Umbleja T, Martin J, Orem J, Godfrey C, Hoagland B, Mwelase N, Langat D, Nyirenda M, MacRae J, Borok-Williams M, Samaneka W, et al. As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29365083 DOI: 10.1093/Cid/Ciy044 |
0.325 |
|
| 2017 |
Shive CL, Judge CJ, Clagett B, Kalayjian RC, Osborn M, Sherman KE, Fichtenbaum C, Gandhi RT, Kang M, Popkin DL, Sieg SF, Lederman MM, Rodriguez B, Anthony DD. Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection. Vaccine. PMID 29254840 DOI: 10.1016/J.Vaccine.2017.12.018 |
0.419 |
|
| 2017 |
Tam E, Luetkemeyer AF, Mantry PS, Satapathy SK, Ghali P, Kang M, Haubrich R, Shen X, Ni L, Camus G, Copans A, Rossaro L, Guyer B, Brown RS. Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naive patients: findings from two randomized trials. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 29091342 DOI: 10.1111/Liv.13616 |
0.328 |
|
| 2017 |
Sherman KE, Kang M, Sterling R, Umbleja T, Marks K, Kiser JJ, Alston-Smith B, Greaves W, Butt AA, The Actg Birth Study Team. Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection. World Journal of Hepatology. 9: 217-223. PMID 28217259 DOI: 10.4254/Wjh.V9.I4.217 |
0.322 |
|
| 2016 |
Judge CJ, Sandberg JK, Funderburg NT, Sherman KE, Butt AA, Kang M, Landay AL, Lederman MM, Anthony DD. CD14brightCD16- monocytes and sCD14 level negatively associate with CD4-memory T-cell frequency and predict HCV-decline on therapy. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 27258231 DOI: 10.1097/Qai.0000000000001104 |
0.332 |
|
| 2016 |
Petersen T, Lee YJ, Osinusi A, Amorosa VK, Wang C, Kang M, Matining R, Zhang X, Dou D, Umbleja T, Kottilil S, Peters MG. Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin. Aids Research and Human Retroviruses. PMID 26974581 DOI: 10.1089/Aid.2015.0236 |
0.356 |
|
| 2016 |
Jacobson J, Bosinger S, Kang M, Belaunzaran-Zamudio P, Matining RM, Wilson C, Flexner CW, Clagett B, Plants J, Read S, Purdue L, Myers L, Boone L, Tebas P, Kumar P, et al. The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. Aids Research and Human Retroviruses. PMID 26935044 DOI: 10.1089/Aid.2015.0336 |
0.346 |
|
| 2015 |
Bedimo R, Kang M, Tebas P, Overton ET, Hollabaugh K, McComsey GA, Bhattacharya D, Evans C, Brown T, Taiwo B. Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers (BTMs) in HIV/HCV Co-Infected Patients. Aids Research and Human Retroviruses. PMID 26499270 DOI: 10.1089/Aid.2015.0204 |
0.352 |
|
| 2015 |
Sherman K, Kang M, Sterling R, Umbleja T, Marks KM, Alston-Smith B, Greaves W. A Prospective Phase 3 Trial of Boceprevir/Pegylated Interferon/Ribavirin for HCV/HIV Coinfected Persons Open Forum Infectious Diseases. 2. DOI: 10.1093/Ofid/Ofv133.619 |
0.363 |
|
| 2014 |
Kojic EM, Kang M, Cespedes MS, Umbleja T, Godfrey C, Allen RT, Firnhaber C, Grinsztejn B, Palefsky JM, Webster-Cyriaque JY, Saah A, Aberg JA, Cu-Uvin S. Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in HIV-1-infected women. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 59: 127-35. PMID 24723284 DOI: 10.1093/Cid/Ciu238 |
0.434 |
|
| 2014 |
Sulkowski MS, Kang M, Matining R, Wyles D, Johnson VA, Morse GD, Amorosa V, Bhattacharya D, Coughlin K, Wong-Staal F, Glesby MJ. Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b study. The Journal of Infectious Diseases. 209: 658-67. PMID 24041792 DOI: 10.1093/Infdis/Jit503 |
0.335 |
|
| 2013 |
Amorosa VK, Luetkemeyer A, Kang M, Johnson VA, Umbleja T, Haas DW, Yesmin S, Bardin MC, Chung RT, Alston-Smith B, Tebas P, Peters MG. Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial. Hiv Clinical Trials. 14: 274-83. PMID 24334180 DOI: 10.1310/Hct1406-274 |
0.343 |
|
| 2013 |
Branch AD, Kang M, Hollabaugh K, Wyatt CM, Chung RT, Glesby MJ. In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use. The American Journal of Clinical Nutrition. 98: 423-9. PMID 23739141 DOI: 10.3945/Ajcn.112.048785 |
0.372 |
|
| 2012 |
Kang M, Cu-Uvin S. Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy. Hiv Medicine. 13: 372-8. PMID 22257000 DOI: 10.1111/J.1468-1293.2011.00979.X |
0.394 |
|
| 2011 |
Anthony DD, Umbleja T, Aberg JA, Kang M, Medvik K, Lederman MM, Peters MG, Koziel MJ, Overton ET. Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals Vaccine. 29: 3558-3563. PMID 21397720 DOI: 10.1016/J.Vaccine.2011.02.092 |
0.341 |
|
| 2010 |
Overton ET, Kang M, Peters MG, Umbleja T, Alston-Smith BL, Bastow B, Demarco-Shaw D, Koziel MJ, Mong-Kryspin L, Sprenger HL, Yu JY, Aberg JA. Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220. Vaccine. 28: 5597-604. PMID 20600512 DOI: 10.1016/J.Vaccine.2010.06.030 |
0.398 |
|
| 2007 |
Kang M, Chung RT. The role of early viral decline in the treatment of hepatitis C in HIV-1-coinfected persons. Journal of Acquired Immune Deficiency Syndromes (1999). 46: 371-3. PMID 18090301 DOI: 10.1097/Qai.0B013E3180Dec9Fc |
0.343 |
|
| 2007 |
Aweeka FT, Kang M, Yu JY, Lizak P, Alston B, Chung RT. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team. Hiv Medicine. 8: 288-94. PMID 17561874 DOI: 10.1111/j.1468-1293.2007.00472.x |
0.322 |
|
| 2007 |
Blackard JT, Kang M, St Clair JB, Lin W, Kamegaya Y, Sherman KE, Koziel MJ, Peters MG, Andersen J, Chung RT. Viral factors associated with cytokine expression during HCV/HIV co-infection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 27: 263-9. PMID 17477814 DOI: 10.1089/Jir.2006.0147 |
0.406 |
|
| 2007 |
Kang M, Lagakos SW. Statistical methods for panel data from a semi-Markov process, with application to HPV. Biostatistics (Oxford, England). 8: 252-64. PMID 16740624 DOI: 10.1093/Biostatistics/Kxl006 |
0.52 |
|
| 2006 |
Blackard JT, Kang M, Sherman KE, Koziel MJ, Peters MG, Chung RT. Effects of HCV treatment on cytokine expression during HCV/HIV coinfection. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 26: 834-8. PMID 17115902 DOI: 10.1089/Jir.2006.26.834 |
0.353 |
|
| 2004 |
Kang M, Lagakos SW. Evaluation of log-rank tests for infrequent observations from a multi-state process, with application to HPV vaccine efficacy. Statistics in Medicine. 23: 3681-96. PMID 15534891 DOI: 10.1002/Sim.1916 |
0.582 |
|
| 2004 |
Kang M, Lagakos SW. Evaluating the role of human papillomavirus vaccine in cervical cancer prevention. Statistical Methods in Medical Research. 13: 139-55. PMID 15068258 DOI: 10.1191/0962280204Sm358Ra |
0.569 |
|
| 2001 |
McFarland EJ, Borkowsky W, Fenton T, Wara D, McNamara J, Samson P, Kang M, Mofenson L, Cunningham C, Duliege AM, Sinangil F, Spector SA, Jimenez E, Bryson Y, Burchett S, et al. Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine. The Journal of Infectious Diseases. 184: 1331-5. PMID 11679925 DOI: 10.1086/323994 |
0.338 |
|
| 2000 |
Borkowsky W, Wara D, Fenton T, McNamara J, Kang M, Mofenson L, McFarland E, Cunningham C, Duliege AM, Francis D, Bryson Y, Burchett S, Spector SA, Frenkel LM, Starr S, et al. Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators. The Journal of Infectious Diseases. 181: 890-6. PMID 10720509 DOI: 10.1086/315298 |
0.379 |
|
| 2000 |
Stiehm ER, Fletcher CV, Mofenson LM, Palumbo PE, Kang M, Fenton T, Sapan CV, Meyer WA, Shearer WT, Hawkins E, Fowler MG, Bouquin P, Purdue L, Sloand EM, Nemo GJ, et al. Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273). The Journal of Infectious Diseases. 181: 548-54. PMID 10669338 DOI: 10.1086/315224 |
0.346 |
|
| 1998 |
Lambert JS, McNamara J, Katz SL, Fenton T, Kang M, VanCott TC, Livingston R, Hawkins E, Moye J, Borkowsky W, Johnson D, Yogev R, Duliege AM, Francis D, Gershon A, et al. Safety and immunogenicity of HIV recombinant envelope vaccines in HIV- infected infants and children Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 19: 451-461. PMID 9859958 DOI: 10.1097/00042560-199812150-00003 |
0.382 |
|
| Show low-probability matches. |